Potential new tool to monitor radiotherapy side effects

Undergraduate Undergraduate Courses Undergraduate Teaching and learning Expanding your study (undergraduate) After you graduate (undergraduate) Download a prospectus (undergraduate) Undergraduate Applications Undergraduate Student finance Taught master's Why Manchester? (taught master's) Taught master's Courses Teaching and learning (taught master's) After you graduate (taught master's) Download a prospectus (taught master's) Admissions process (taught master's) Fees for taught master's study Funding for taught master's study us (taught master's) Postgraduate research Programmes People (postgraduate research) Admissions (postgraduate research) Fees for postgraduate research Funding for postgraduate research us (postgraduate research) Postgraduate certificates and diplomas Online and distance learning International Why study at Manchester? (for international students) Accommodation for international students 07 Jan 2015 Researchers in Manchester have investigated a patient-centred approach to assessing the side effects of radiotherapy and have shown that it may be able to improve the detection and management of treatment-related toxicity. For lung cancer that cannot be removed with surgery, radiotherapy is the primary treatment option. However, it is associated with a range of side effects, including fatigue and inflammation of the oesophagus and lungs. Current methods to record treatment-related toxicities rely on assessment by health care professionals. Now a team from The University of Manchester and The Christie NHS Foundation Trust - both part of the Manchester Cancer Research Centre - has explored the use of patient-reported outcomes to improve the recording of side effects for lung cancer patients.